Life sciences employer
Allogene Therapeutics
7 open positions7 US roles1 remote-friendly
- Active openings
- 7
- US-based roles
- 7
- Remote-friendly
- 1
- Last updated
- 2026-08-28
What Allogene Therapeutics is hiring for
Open positions
7 active- Maintenance TechnicianNewark, CAAug 28
- Sr. Assoc. Scientist, Process and Product Development (Contract)South San Francisco, CAAug 28
- Senior Associate Scientist, Analytical Science (Contract)South San Francisco, CAAug 27
- Sr. Scientist, Gene Editing Materials Process Development(temp)CAAug 26
- Coordinator, Corporate AffairsHybrid in South San Francisco, CAAug 22
About Allogene Therapeutics
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker
Sep 2, 2026
Allogene Therapeutics Announces Participation in September Investor Conference
Aug 31, 2026
Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update
Aug 12, 2026
August 12, 2026 5:00 PM EDT : The Allogene Therapeutics Second Quarter 2026 Conference Call
Aug 4, 2026
Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update
Aug 4, 2026
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma
Jul 29, 2026